A new, technologically advanced laboratory will occupy ten thousand square feet of the Stem Cell Storage Facility and will produce quality Beike stem cells for use in treating patients in the leading hospitals of China's Jiangsu Province and greater Shanghai regions. Beike's stem cells are already used nationally in some of China's leading hospitals to treat more than 200 patients per month suffering from a range of debilitating disorders like Ataxia, Brain Injury, Cerebral Palsy, Diabetic Feet, Lower Limb Ischemia, Multiple Sclerosis, Muscular Dystrophy, Spinal Cord Injury and Optic Nerve Damage. This new central processing laboratory model supersedes Beike's prior need to build laboratories inside hospitals, meaning Beike treatments will become more affordable as stem cell component costs are reduced, fulfilling Beike's mission to improve the quality of life for as many patients as possible.
The Stem Cell Storage Facility, which is set to be fully functional by
year end 2008, is located next to the 15,000 square foot Jiangsu Beike
Biotechnology office building, which already houses a showroom showcasing
Beike's technologies and treatments. Beike ultimately plans for the entire
facility to be able to house up to 100,000 stem cell samples. To mark its
formal establishment, Beike hosted a grand opening ceremony at the site of
the facility which is located in Taizhou City within the prosperous eastern
province of Jiangsu. Jiangsu is rapidly becoming known as China's biotech
and medical capital, with Taizhou being touted by Chinese officials as
"China Medical City" (CMC). Several provincial and local officials were in
attendance at the ceremony including Mr. He Rong, The Assistant Mayor of
Taizhou and Director of the Taizhou New Medical Technology Industrial Park,
|SOURCE Shenzhen Beike Biotechnology Co., Ltd.|
Copyright©2008 PR Newswire.
All rights reserved